A rival to trendy weight loss drug semaglutide has been shown to drastically improve blood pressure after 36 weeks of taking the medication,For the study, an international team of scientists sponsored by Eli Lilly looked at the blood pressure of 494 patients at the start of the study and then measured their blood pressure at the 36-week mark, with readings done throughout a 24-hour period for more granular data.
The results at the end of the study were significant. Participants on tirzepatide experienced a reduction in systolic blood pressure — that's the first number in a blood pressure reading, which gauges the pressure inside arteries during a heartbeat — of anywhere between 7.4 to 10.6 millimeters lower versus being in the placebo group.